Question to CHATGPT (just now):
Have clinical trials shown that Viraleze prevents Covid?
CHATGPT:
Clinical trials on Viraleze have not provided conclusive evidence that it prevents COVID-19. While Viraleze is marketed as a nasal spray that may reduce viral loads in the nasal cavity, its specific efficacy against COVID-19 has not been extensively validated in large-scale, peer-reviewed studies. The product may have some antiviral properties, but it is not considered a primary preventive measure for COVID-19. Vaccines, social distancing, and other established public health measures remain the most effective strategies for preventing COVID-19.
Oh dear, minions won’t be happy, but thanks for the clarification CHATGPT. Lol.
Now where is that Viraleze, page-54
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.006(6.38%) |
Mkt cap ! $41.73M | |||
| Open | High | Low | Value | Volume |
| 9.6¢ | 10.5¢ | 9.6¢ | $119.8K | 1.209M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 98000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 175467 | 3 |
View Market Depth
| Last trade - 12.15pm 16/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |